drugset / Trial / NCT01776320
Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction
Phase 4
Withdrawn
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
NaSingle-groupOpen-labelTreatment
Summary
A Phase 4 clinical trial that is open, with no blinding of subjects or randomization of treatment. Patients with erectile problems will be given the approved drug Vitaros to treat their condition. They will be given forms and questionnaires to complete. The information collected will be used to assess the effectiveness, safety and the satisfaction levels with this drug.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-12
- Completion
- 2015-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprostadil | Unknown | 330 ug | Topical |